CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 4 Open-market sale President & CEO sold 3,359 shares at $18.86 ($63,361)
- 4 Open-market sale Chief Medical Officer sold 1,015 shares at $18.86 ($19,146)
- 4 Open-market sale Chief Product Officer sold 1,089 shares at $18.86 ($20,542)
- 4 Open-market sale Chief Commercial Officer sold 848 shares at $18.86 ($15,996)
- 4 Open-market sale Chief Financial Officer sold 1,462 shares at $18.86 ($27,578)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 4,413 shares at $17.01 ($75,083)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer sold 16,158 shares at $16.61 ($268,376)
- 4 Planned sale Chief Financial Officer sold 5,587 shares at $17.03 ($95,172)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
Page 9 of 15 · 290 filings